Loading…
Loading…
EQUITY / NASDAQ · XNMS
Ascentage Pharma Group International
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2024 – 12/31/2024 · CNY · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗16.31 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 16.31 USD · Volume 13,737
251 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
2 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2024 – 12/31/2024 · Units
| Metric | 2024 / Year end | 2023 / Year end | Change |
|---|---|---|---|
| Revenue | 980,650,000 CNY | 221,984,000 CNY | +341.77% |
| Net income | -405,680,000 CNY | -925,712,000 CNY | — |
| Operating cash flow | -111,357,000 CNY | -726,077,000 CNY | — |
| Cash and cash equivalents | 893,100,000 CNY | 1,038,048,000 CNY | -13.96% |
| Total liabilities | 2,343,648,000 CNY | 2,429,761,000 CNY | -3.54% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · CNY | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · CNY |
|---|---|---|
| Cash and cash equivalentsBalance sheet | 893,100,000 CNY | 1,038,048,000 CNY |
| Financing cash flowCash flow statement | 314,767,000 CNY | 368,751,000 CNY |
| Gross profitIncome statement | 951,565,000 CNY | 191,441,000 CNY |
| Investing cash flowCash flow statement | -362,035,000 CNY | 21,922,000 CNY |
| Net incomeIncome statement | -405,680,000 CNY | -925,712,000 CNY |
| Operating cash flowCash flow statement | -111,357,000 CNY | -726,077,000 CNY |
| RevenueIncome statement | 980,650,000 CNY | 221,984,000 CNY |
| Total equityBalance sheet | 274,162,000 CNY | 70,632,000 CNY |
| Total liabilitiesBalance sheet | 2,343,648,000 CNY | 2,429,761,000 CNY |
| Report source | Open report ↗ Published: 04/16/2025 | Open report ↗ Published: 04/16/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.